Impax Got Earliest Possible Generic Opana Entry, Jury Hears
By Lauraann Wood · June 14, 2022, 9:17 PM EDT
In an ongoing antitrust trial over an alleged pay-for-delay scheme surrounding Endo Pharmaceuticals' Opana ER painkiller, a former Impax Laboratories executive testified Tuesday that the generic-drug maker had always pushed to...
To view the full article, register now.